Have a personal or library account? Click to login
Lack of Association Between Rs2067474 Polymorphism in the Histamine Receptor H2 Gene and Gastric Cancer In Latvian Population Cover

Lack of Association Between Rs2067474 Polymorphism in the Histamine Receptor H2 Gene and Gastric Cancer In Latvian Population

Open Access
|Dec 2018

References

  1. Alzahrani, S., Lina, T. T., Gonzalez, J., Pinchuk, I. V., Beswick, E. J., Reyes, V. (2014). Effect of Helicobacter pylori on gastric epithelial cells. World J. Gastroenterol.,20 (36), 12767–12780.10.3748/wjg.v20.i36.12767
  2. Anonymous (1994). Schistosomes, liver flukes and Helicobacter pylori. World Health Organisation, International Agency for Research on Cancer (IARC) Working Group on the evaluation of carcinogenic risks to human. IARC Monogr. Eval. Carcinog. Risks Hum., 61, 269.
  3. Arisawa, T., Tahara, T., Ozaki, K., Matsue, Y., Minato, T., Yamada, H., Nomura, T., Hayashi, R., Matsunaga, K., Fukumura, A., Nakamura, M., Toshkuni, N., Shiroeda, H., Shibata, T. (2012). Association between common genetic variant of HRH2 and gastric cancer risk. Int. J. Oncol., 41 (2), 487–503.10.3892/ijo.2012.1482
  4. Auton, A., Brooks, L. D., Durbin, R. M., Garrison, E. P., Kang, H. M., Korbel, J. O., Marchini, J. L., McCarthy, S., McVean, G. A., Abecasis, G. R., 1000 Genomes Project Consortium (2015). A global reference for human genetic variation. Nature,526 (7571), 68–74.
  5. Bosman, F. T., Carneiro, F., Hruban, R. H., Theise, N. D. (eds.) (2010). IARC WHO Classification of Tumours of the Digestive System, fourth edition. World Health Organization, Lyon. 418 pp.
  6. Cai, W. K., Zhang, J. B., Wang, N. M., Wang, Y. L., Lu, J., He, G. H. (2015). Lack of association between rs2067474 polymorphism in histamine receptor H2 gene and breast cancer in Chinese Han population. Sci. World J.,2015, 545292.10.1155/2015/545292
  7. Ched, D., Aihara, T., Zhao, C. M., Hakanson, R., Okabe, S. (2006). Differentiation of the gastric mucosa. I. Role of histamine in control of function and integrity of oxyntic mucosa: Understanding gastric physiology through disruption of targeted genes. Amer. J. Physiol. Gastrointest. Liver Physiol., 291 (4), G539–G544.10.1152/ajpgi.00178.2006
  8. Dixon, M. F., Genta, R. M., Yardley, J. H., Correa, P. (1996). Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Amer. J. Surg. Pathol., 20 (10), 1161–1181.10.1097/00000478-199610000-00001
  9. de Esch, I. J., Thurmond, R. L., Jongejan, A., Leurs, R. (2005). The histamine H4 receptor as a new therapeutic target for inflammation. Trends in Pharmacol. Sci.,26 (9), 462–469.10.1016/j.tips.2005.07.002
  10. Edge, S. B., Byrd, D. R., Compton, C. C., Fritz, A. G., Greene, F. L., Trotti, A. (eds.) (2009). AJCC Cancer Staging Manual. 7th edn. Springer-Verlag, New York. 648 pp.
  11. Ermani, S., Gespach, C., Forgue-Lafitte, M. E., Broer, Y., Rosselin, G. (1983). Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1. Life Sci., 33 (5), 415–423.10.1016/0024-3205(83)90789-0
  12. Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., Bray, F. (eds.) (2013). GLOBOCAN 2012: Estimated Cancer Incidence and Mortality Worldwide in 2012. IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon. Available from http://globocan.iarc.fr (accessed 03.11.2017).
  13. Garcia-Martin, E., Ayuso, P., Luengo, A., Martinez, C., Agudez, J. A. (2008). Genetic variability of histamine receptors in patients with Parkinson’s disease. BioMed Central Med. Gen.,9, 15.10.1186/1471-2350-9-15
  14. Gricco, G. P., Mohamad, N. A., Sambuco, L. A., Genre, F., Croci, M., Gutierrez, A. S., Medina, V. A., Bergoc, R. M., Rivera, E. S., Martin, G. A. (2008). Histamine regulates pancreatic carcinoma cell growth through H3 and H4 receptors. Inflamm. Res.,57 (Suppl 1), S23–S24.10.1007/s00011-007-0611-5
  15. Guo, Y., Jamison, D. C. (2005). The distribution of SNPs on human gene regulatory regions. BioMed Central Genom., 6, 140.10.1186/1471-2164-6-140
  16. Hakanson, R., Bottcher, G., Ekblad, E., Panula, P., Simonsson, M., Dohlsten, M., Hallberg, T., Sundler, F. (1986). Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine. Histo-chemistry, 86 (1), 5–17.10.1007/BF00492340
  17. Hill, S. J., Ganellin, C. R., Timmerman, H., Schwartz, J. C., Shankley, N. P., Young, J. M., Schunack, W., Levi, R., Hass, H. L. (1997). International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmac. Rev., 49 (3), 253–278.
  18. Kong, W. Q., Bai, R., Liu, T., Cai, C. L., Liu, M., Li, X., Tang, H. (2012). MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS J.,279 (7), 1252–1260.10.1111/j.1742-4658.2012.08519.x
  19. Lampiasi, N., Azzolina, A., Montalto, G., Cervello, M. (2007). Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells. Exper. Mol. Med., 39 (3), 284–294.10.1038/emm.2007.32
  20. Lauren, P. (1965). The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Et Microbiol. Scand.,64, 31–49.10.1111/apm.1965.64.1.31
  21. Mancama, D., Arranz, M. J., Munro, J., Osborne, S., Makoff, A., Collier, D., Kerwin, R. (2002). Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response. Neurosci. Lett.,333 (3), 207–211.10.1016/S0304-3940(02)00178-7
  22. McGowan, C. C., Cover, T. L., Blaster, M. J. (1996). Helicobacter pylori and gastric acid: Biological and therapeutic implications. Gastroenterology, 110 (3), 926–938.10.1053/gast.1996.v110.pm86089048608904
  23. Nomura, T., Tahara, T., Shiroeda, H., Minato, T., Matsue, Y., Hayashi, R., Matsunaga, K., Otsuka, T., Nakamura, M., Toshikuni, N., Shibata, T., Arisawa, T. (2013). Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium. BioMed Central Gastroenterol., 13,1.10.1186/1471-230X-13-1
  24. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., Sibley, R. K. (1991). Helicobacter pylori infection and the risk of gastric carcinoma. New Engl. J. Med., 325 (16), 1127–1131.10.1056/NEJM1991101732516031891020
  25. Rugge, M., Capelle, L. G., Cappellesso, R., Nitti, D., Kuipers, E. J. (2013). Precancerous lesions in the stomach: From biology to clinical patient management. Best Practice Res. Clin. Gastroenterol., 27, 205–223.10.1016/j.bpg.2012.12.007
  26. Wroblewski, L. E., Peek, R. M., Wilson, K. T. (2010). Helicobacter pylori and gastric cancer: Factors that modulate disease risk. Clin. Microbiol. Rev., 23 (4), 713–739.10.1128/CMR.00011-10295298020930071
  27. Yamada, H., Tahara, T., Shiroeda, H., Hayashi, R., Saito, T., Nakamura, M., Tsuchishima, M., Tsutsumi, M., Shibata, T., Arisawa, T. (2012). Effects of –1018 G A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy. J. Gastrointest. Liver Dis.,21 (2), 139–143.
DOI: https://doi.org/10.2478/prolas-2018-0044 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 307 - 312
Submitted on: Dec 4, 2017
|
Accepted on: Aug 18, 2018
|
Published on: Dec 26, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2018 Georgijs Moisejevs, Linda Gailīte, Sergejs Isajevs, Liene Ņikitina-Zaķe, Inga Kempa, Dainius Jančiauskas, Ilze Ķikuste, Armands Sīviņš, Guntis Ancāns, Mārcis Leja, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.